ADAPTOGEN COMPLEX Trademark

Trademark Overview


On Thursday, April 4, 2024, a trademark application was filed for ADAPTOGEN COMPLEX with the United States Patent and Trademark Office. The USPTO has given the ADAPTOGEN COMPLEX trademark a serial number of 98485137. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, October 28, 2024. The ADAPTOGEN COMPLEX trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements
adaptogen complex

General Information


Serial Number98485137
Word MarkADAPTOGEN COMPLEX
Filing DateThursday, April 4, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary and nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 4, 2024
Primary Code005
First Use Anywhere DateMonday, December 10, 2018
First Use In Commerce DateWednesday, May 1, 2019

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressChandler, AZ 85286

Trademark Events


Event DateEvent Description
Thursday, April 4, 2024NEW APPLICATION ENTERED
Thursday, April 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 18, 2024ASSIGNED TO EXAMINER
Monday, October 28, 2024NON-FINAL ACTION WRITTEN
Monday, October 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 28, 2024NON-FINAL ACTION E-MAILED